Ohr Pharmaceutical, Inc.

[NASDAQ: OHRP]; based in New York, New York; incorporated in Delaware

Deadline: 04/16/2018

Case #: 18-cv-1284

Court: USDC, Southern District of New York

Lead or Derivative; Class Period is 6/24/2014 to 1/4/2018